Please sign in to follow a disease.
Platelet-type bleeding disorder 10
MONDO:0012031Any inherited bleeding disorder, platelet-type in which the cause of the disease is a mutation in the CD36 gene.
Also known as: BDPLT10, CD36 deficiency, CD36 inherited bleeding disorder, platelet-type, inherited bleeding disorder, platelet-type caused by mutation in CD36, platelet-type bleeding disorder 10, bleeding disorder, Platelet-type, 10, platelet glycoprotein 4 deficiency
21 clinical trials for this condition and its sub-types, 8 tagged with Platelet-type bleeding disorder 10 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug combo aims to supercharge weight loss in obesity trial
Disease control OngoingThis phase 2 study tests two drugs, bimagrumab and tirzepatide, alone or together, to see if they help adults with obesity or overweight lose weight safely. About 252 participants without type 2 diabetes will take the drugs or a placebo for up to 70 weeks. The main goal is to mea…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Weight-Loss drug combo study pulled before starting
Disease control CancelledThis study aimed to test two drugs, bimagrumab and tirzepatide, alone or together, for helping adults with obesity or overweight and type 2 diabetes lose weight. It was planned for about 13 months but was withdrawn before enrolling any participants. The main goal was to see how m…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC